JP2002515223A - Ｔａｏプロテインキナーゼおよびその使用方法 - Google Patents

Ｔａｏプロテインキナーゼおよびその使用方法

Info

Publication number
JP2002515223A
JP2002515223A JP2000543623A JP2000543623A JP2002515223A JP 2002515223 A JP2002515223 A JP 2002515223A JP 2000543623 A JP2000543623 A JP 2000543623A JP 2000543623 A JP2000543623 A JP 2000543623A JP 2002515223 A JP2002515223 A JP 2002515223A
Authority
JP
Japan
Prior art keywords
polypeptide
mek3
polynucleotide
seq
tao1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000543623A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002515223A5 (enExample
Inventor
メラニ− コブ，
ミッシェル ハッチソン，
ズ チェン，
ケビン ベルマン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of JP2002515223A publication Critical patent/JP2002515223A/ja
Publication of JP2002515223A5 publication Critical patent/JP2002515223A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2000543623A 1998-04-14 1999-04-14 Ｔａｏプロテインキナーゼおよびその使用方法 Pending JP2002515223A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/060,410 1998-04-14
US09/060,410 US6165461A (en) 1998-04-14 1998-04-14 Tao protein kinases and methods of use therefor
PCT/US1999/008165 WO1999053076A1 (en) 1998-04-14 1999-04-14 Tao protein kinases and methods of use therefor

Publications (2)

Publication Number Publication Date
JP2002515223A true JP2002515223A (ja) 2002-05-28
JP2002515223A5 JP2002515223A5 (enExample) 2006-06-08

Family

ID=22029289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000543623A Pending JP2002515223A (ja) 1998-04-14 1999-04-14 Ｔａｏプロテインキナーゼおよびその使用方法

Country Status (8)

Country Link
US (2) US6165461A (enExample)
EP (1) EP1071787A1 (enExample)
JP (1) JP2002515223A (enExample)
CN (1) CN100374568C (enExample)
AU (1) AU758731B2 (enExample)
BR (1) BR9909679A (enExample)
CA (1) CA2325824A1 (enExample)
WO (1) WO1999053076A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078182B1 (en) 1998-04-14 2006-07-18 Board Of Regents, The University Of Texas System TAO protein kinase polypeptides and methods of use therefor
US6165461A (en) 1998-04-14 2000-12-26 Board Of Regents, University Of Texas System Tao protein kinases and methods of use therefor
US7148330B2 (en) 1999-07-30 2006-12-12 Schering Corporation Binding compounds for IL-27
US6806293B1 (en) 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
WO2002072809A1 (en) * 2001-03-12 2002-09-19 Alydar Pharmaceuticals, Inc. Screening non-peptide, non-steroid invertebrate pheromone compounds for mitogen-activated protein kinase modulating activity
ATE483976T1 (de) 2001-06-05 2010-10-15 Exelixis Inc Gfats als modifikatoren des p53-wegs und verwendungsverfahren
AU2002324598A1 (en) * 2001-08-06 2003-02-24 Exelixis, Inc. Trps as modifiers of the p53 pathway and methods of use
AU2002357174A1 (en) * 2001-12-13 2003-06-30 Exelixis, Inc. Taojiks as modifiers of the beta-catenin pathway and methods of use
WO2004012817A2 (en) * 2002-07-31 2004-02-12 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
US7282479B2 (en) * 2003-03-31 2007-10-16 Ttc Co., Ltd. Hyperthermia agent for malignant tumor comprising cytokine and magnetic fine particles
EP1514558A1 (en) * 2003-09-15 2005-03-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of MARKK or MARKK antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of MARK or tau protein
US20100122354A1 (en) * 2005-06-20 2010-05-13 Exelixis, Inc. Cdc6s as modifiers of the pten/akt pathway and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4326097A (en) * 1996-07-03 1998-01-21 Chiron Corporation (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip)
AU8296698A (en) * 1997-07-08 1999-02-08 Cadus Pharmaceutical Corporation (kds) protein kinase molecules and uses related thereto
US6165461A (en) 1998-04-14 2000-12-26 Board Of Regents, University Of Texas System Tao protein kinases and methods of use therefor

Also Published As

Publication number Publication date
CN100374568C (zh) 2008-03-12
AU758731B2 (en) 2003-03-27
AU3560599A (en) 1999-11-01
CA2325824A1 (en) 1999-10-21
CN1303435A (zh) 2001-07-11
WO1999053076A9 (en) 2001-03-15
EP1071787A1 (en) 2001-01-31
BR9909679A (pt) 2000-12-19
WO1999053076A1 (en) 1999-10-21
US6586242B1 (en) 2003-07-01
US6165461A (en) 2000-12-26

Similar Documents

Publication Publication Date Title
CA2207581A1 (en) Probin tyrosine kinase (pyk2) its cdna cloning and its uses
US20030175928A1 (en) Mitogen-activated protein kinase MEK6 and methods of use therefor
AU736316B2 (en) Mitogen-activated protein kinase p38-2 and methods of use therefor
US20030078222A1 (en) Human receptor tyrosine kinase
JP2002515223A (ja) Ｔａｏプロテインキナーゼおよびその使用方法
US6444455B1 (en) Mitogen-activated protein kinase P38-2 and methods of use therefor
US6541615B1 (en) SIRP proteins and uses thereof
JPH11123086A (ja) セリン−トレオニンプロテインキナーゼ（ｈ−ｓｇｋ２）
CA2331889A1 (en) Nek-related and bub1-related protein kinases
US20030087317A1 (en) Human NIM1 kinase
JP2001517430A (ja) ヒトＳｔｅ２０様ストレス活性化セリン／スレオニンキナーゼ
JP4472179B2 (ja) 新規なリボゾームｓ６プロテインキナーゼの同定および機能的なキャラクタライゼーション
JP2001157590A (ja) 紫外線照射仲介皮膚損傷に関連する遺伝子およびポリヌクレオチド並びにそれらの使用
US7078182B1 (en) TAO protein kinase polypeptides and methods of use therefor
JP2002186495A (ja) 新規ｈａｓ２スプライシング変種ｈｏｅｆｃ１１：慢性腎不全、炎症性疾患および心筋虚血における標的
US6677130B1 (en) Mitogen-activated protein kinase p38-2 and methods of use therefor
EP1090987A1 (en) Cell cycle regulatory factor
US20040151713A1 (en) Cell cycle regulatory factor
US6372467B1 (en) P54s6k and p85s6k genes, proteins, primers, probes, and detection methods
JP3980635B2 (ja) 外部シグナルに対する細胞応答性を調節するための方法および生成物
JPH11137264A (ja) Ｙａｋ−１ 関連セリン／トレオニンプロテインキナーゼ− ｈｔｌａｒ３３
JP2003506081A (ja) ＮＦ−κＢ活性化に関与するプロテインキナーゼＣ相互作用性タンパク質
US20040132025A1 (en) Ampk-related serine/threonine kinase, designated snark
JPWO1999067369A1 (ja) 細胞周期調節因子

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060411

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060411

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090114

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090610